New drug trial aims to tame painful joint and skin disease
NCT ID NCT07295509
Summary
This study is testing a new injectable drug called picankibart for people with active psoriatic arthritis, a condition that causes joint pain, swelling, and skin plaques. Over 200 participants will receive either the drug or a placebo injection to see if it safely reduces joint symptoms and improves physical function and skin health. The main goal is to see how many people experience at least a 20% improvement in their joint pain and swelling after 24 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.